Challenges and innovations in patient selection, biomarkers, and personalized treatments within the I-O landscape

Lauren Coyle, Commissioning Editor of Immuno-Oncology Insights, speaks with Oliver Rosen, Chief Medical Officer of Akamis Bio, to discuss the impact of accurate patient selection on the effectiveness of I-O treatments and the limitations of current biomarkers in patient selection.

Institutions

OBS Medical (United Kingdom) (GB)

Publication Details

Journal: Immuno Oncology Insights
Published: 2024-09-04
DOI: https://doi.org/10.18609/ioi.2024.016
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Challenges and innovations in patient selection, biomarkers, and personalized treatments within the I-O landscape

Sep 4, 2024

Immuno Oncology Insights

Cancer Immunotherapy and Biomarkers

article

Challenges and innovations in patient selection, biomarkers, and personalized treatments within the I-O landscape

September 4, 2024article en

Abstract

Immuno Oncology InsightsVol. 5(3)

OBS Medical (United Kingdom) (GB)

Openalex Percentile: Top 43%

Cancer Immunotherapy and Biomarkers

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Challenges and innovations in patient selection, biomarkers, and personalized treatments within the I-O landscape · Immuno Oncology Insights (2024) | TGRS Research Map | TGRS